Oncology Market Access Strategy Summit
February 20th-21st
This was TikaMobile’s first year in attendance of the 12th Annual Oncology Market Access Strategy Summit.
San Francisco, California
PharmaTimes: News RSS
- Evgen scores full approval for COVID-19 trial launch
- Parkinson’s UK partners with UCL on phase II trial
- Bayer to acquire cell and gene therapy specialist AskBio
- AZ presents new real-world chronic kidney disease data at ASN 2020
- Merck KGaA, IAVI and Serum Institute link up to develop COVID-19 mAbs
- BMS partners with Sensyne Health for rare blood disease research
- ICR urges change as NICE rejects Keytruda plus chemotherapy
- Gilead’s COVID-19 drug remdesivir bags US approval
- STORM Therapeutics’ METTL3 inhibitor moves closer to the clinic
- Pharming’s APDS drug scores EU orphan status
English
Arabic
Chinese (Simplified)
Dutch
English
French
German
Italian
Portuguese
Russian
Spanish